Market open
Cibus Inc./$CBUS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
Ticker
$CBUS
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
158
Website
Cibus Inc. Metrics
BasicAdvanced
$52M
-
-$10.83
2.05
-
Price and volume
Market cap
$52M
Beta
2.05
52-week high
$2.73
52-week low
$1.40
Financial strength
Current ratio
0.853
Quick ratio
0.778
Long term debt to equity
32.147
Total debt to equity
37.09
Interest coverage (TTM)
-2.25%
Management effectiveness
Return on assets (TTM)
-10.76%
Return on equity (TTM)
-129.65%
Valuation
Price to revenue (TTM)
8.663
Price to book
0.48
Price to tangible book (TTM)
-0.23
Price to free cash flow (TTM)
-0.627
Growth
Revenue change (TTM)
134.56%
Earnings per share change (TTM)
-58.28%
3-year revenue growth (CAGR)
-45.26%
3-year earnings per share growth (CAGR)
-34.74%
Cibus Inc. News
AllArticlesVideos
Cibus, Inc. (CBUS) Q4 2024 Earnings Call Transcript
Seeking Alpha·3 weeks ago
Cibus Reports Fourth Quarter Financial Results and Provides Business Update
GlobeNewsWire·3 weeks ago
Cibus Welcomes the European Union's Progress as Legislation for New Genomic Techniques to Boost Innovation and Sustainability Moves Forward
GlobeNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Cibus Inc. stock?
Cibus Inc. (CBUS) has a market cap of $52M as of April 08, 2025.
What is the P/E ratio for Cibus Inc. stock?
The price to earnings (P/E) ratio for Cibus Inc. (CBUS) stock is 0 as of April 08, 2025.
Does Cibus Inc. stock pay dividends?
No, Cibus Inc. (CBUS) stock does not pay dividends to its shareholders as of April 08, 2025.
When is the next Cibus Inc. dividend payment date?
Cibus Inc. (CBUS) stock does not pay dividends to its shareholders.
What is the beta indicator for Cibus Inc.?
Cibus Inc. (CBUS) has a beta rating of 2.05. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.